About Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical is a company based in Toyama (Japan) founded in 1965. Nichi-Iko Pharmaceutical has completed 1 acquisition, including Sagent Pharma.
- Headquarter Toyama, Japan
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nichi-Iko Pharmaceutical
Detailed funding history for Nichi-Iko Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sagent Pharma.
Investment portfolio details for Nichi-Iko Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Injectable generic pharmaceuticals are supplied across multiple therapeutic categories.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Nichi-Iko Pharmaceutical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Nichi-Iko Pharmaceutical
Detailed financials for Nichi-Iko Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nichi-Iko Pharmaceutical Comparisons
Peer comparison for Nichi-Iko Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nichi-Iko Pharmaceutical
Detailed competitors of Nichi-Iko Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nichi-Iko Pharmaceutical
Complete news archive for Nichi-Iko Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical was founded in 1965.
Nichi-Iko Pharmaceutical is headquartered in Toyama, Japan. It is registered at Toyama, Toyama, Japan.
Yuichi Tamura is the current CEO of Nichi-Iko Pharmaceutical.
Nichi-Iko Pharmaceutical was established in 1965 in Toyama, Japan, within the generic and biosimilar pharmaceutical sector. A variety of medications is developed, produced, and distributed through the complete lifecycle, including research, manufacturing, and supply chains. Affordable options are made available to patients globally. Quality standards are enforced across all stages to uphold safety and effectiveness. Support materials are furnished for patients and healthcare providers.
Nichi-Iko Pharmaceutical has made 1 acquisition, including Sagent Pharma.